Literature DB >> 3037703

Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor.

J L Arriza, C Weinberger, G Cerelli, T M Glaser, B L Handelin, D E Housman, R M Evans.   

Abstract

Low-stringency hybridization with human glucocorticoid receptor (hGR) complementary DNA was used to isolate a new gene encoding a predicted 107-kilodalton polypeptide. Expression studies demonstrate its ability to bind aldosterone with high affinity and to activate gene transcription in response to aldosterone, thus establishing its identity as the human mineralocorticoid receptor (hMR). This molecule also shows high affinity for glucocorticoids and stimulates a glucocorticoid-responsive promoter. Together the hMR and hGR provide unexpected functional diversity in which hormone-binding properties, target gene interactions, and patterns of tissue-specific expression may be used in a combinatorial fashion to achieve complex physiologic control.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3037703     DOI: 10.1126/science.3037703

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  309 in total

1.  Induction of mineralocorticoid receptor by sodium butyrate in small intestinal (IEC6) and colonic (T84) epithelial cell lines.

Authors:  K Fukushima; I Sasaki; S Sato; H Sasano; Z Krozowski; S Matsuno
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

2.  Differential DNA binding by the androgen and glucocorticoid receptors involves the second Zn-finger and a C-terminal extension of the DNA-binding domains.

Authors:  E Schoenmakers; P Alen; G Verrijdt; B Peeters; G Verhoeven; W Rombauts; F Claessens
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

3.  The N-terminal domain of the mineralocorticoid receptor modulates both mineralocorticoid receptor- and glucocorticoid receptor-mediated transactivation from Na/K ATPase beta1 target gene promoter.

Authors:  A Derfoul; N M Robertson; D J Hall; G Litwack
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

4.  Influence of aldosterone on collagen synthesis and proliferation of rat cardiac fibroblasts.

Authors:  K Rombouts; A Wielant; K Hellemans; D Schuppan; A Geerts
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

Review 5.  Aldosterone antagonists in the treatment of hypertension and target organ damage.

Authors:  S Rajagopalan; B Pitt
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

6.  Placental growth factor mediates aldosterone-dependent vascular injury in mice.

Authors:  Iris Z Jaffe; Brenna G Newfell; Mark Aronovitz; Najwa N Mohammad; Adam P McGraw; Roger E Perreault; Peter Carmeliet; Afshin Ehsan; Michael E Mendelsohn
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

Review 7.  Apparent mineralocorticoid excess syndromes.

Authors:  M Shimojo; P M Stewart
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

Review 8.  Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome.

Authors:  Miki Nagase
Journal:  Clin Exp Nephrol       Date:  2010-06-09       Impact factor: 2.801

Review 9.  Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.

Authors:  Patrick W F Hadoke; Javaid Iqbal; Brian R Walker
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

Review 10.  Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges.

Authors:  Shuaibo Huang; Nikolaos G Frangogiannis
Journal:  Br J Pharmacol       Date:  2018-03-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.